This vaccine helps protect children against six serious diseases: diphtheria, tetanus (lockjaw), pertussis (whooping cough), hepatitis B, polio, and Haemophilus influenzae type b (Hib) infection.
INFANRIX HEXA is listed under Health Canada DIN 02253852. The product record and monograph below describe this formulation; the dose schedule comes from the Canadian Immunization Guide.
At a glance
Brand
INFANRIX HEXA
DIN
02253852
Vaccine
DTaP-IPV-Hib-HepB
Presentation
0.5 mL · suspension · intramuscular · 6 weeks to 6 years
Live vaccine
No
Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with a healthcare professional.
Official sources
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
A listed product may not be stocked or publicly funded.
Before and after your vaccination
Bring your immunization record if you have one, so earlier doses can be checked.
Tell the healthcare professional about a serious reaction to a previous vaccine or an ingredient, and mention any health conditions or medicines that could affect your vaccination.
After the dose, stay where you can be observed for at least 15 minutes. Tell someone right away if you feel faint or develop symptoms of an allergic reaction.
Keep a record of the vaccine name, date and dose you received.
The details below are adapted from a Pharmasist patient handout linked to the same product monograph. The current Canadian Immunization Guide determines the dose schedules shown later.
What this vaccine helps prevent
This vaccine helps protect children against six serious diseases: diphtheria, tetanus (lockjaw), pertussis (whooping cough), hepatitis B, polio, and Haemophilus influenzae type b (Hib) infection.
It is given to infants and children from 6 weeks up to 2 years of age.
What to mention before a dose
Tell the healthcare professional if your child is allergic to any ingredient in this vaccine, or has had an allergic reaction after a previous dose of this or a similar vaccine.
Tell them if your child had a serious reaction, such as a high fever, collapse, or crying for 3 hours or more, within 48 hours of a previous pertussis vaccine dose.
Tell them if your child has had a seizure within 3 days of a previous vaccine dose, or if there is a family history of seizures.
Tell them if your child has a nervous system condition, such as uncontrolled epilepsy or a brain disease.
Tell them if your child has a weakened immune system or bleeding problems.
Tell them if your child currently has a high fever or infection.
Tell them if your child was born prematurely.
How it is given
A healthcare professional will give this vaccine as a shot into your child's muscle, usually in the thigh or upper arm.
This vaccine comes in two parts, a liquid and a powder, that are mixed together by the healthcare professional right before your child's shot.
This vaccine must not be mixed with any other vaccine in the same syringe.
Important things to know
As with any vaccine, this vaccine may not fully protect every child who receives it.
Fainting can happen as a reaction to any needle injection.
This vaccine should not be given to a child who has had a nervous system problem within 7 days after a previous dose of a pertussis-containing vaccine.
Giving this vaccine at the same time as a pneumococcal vaccine can increase the chance of fever compared with giving it alone.
See a doctor right away if your child collapses, loses consciousness or awareness, or has a seizure (with or without fever) after vaccination. These reactions are very rare but can happen within 2 to 3 days after a whooping cough vaccine.
Effects you may notice
Loss of appetite
Irritability or fussiness
Unusual crying
Restlessness
Pain, redness, or swelling where the shot was given
Fever
Sleepiness
Nervousness
Vomiting
Diarrhea
A larger area of swelling, redness, or a hard lump at the injection site
Itching
A cold or other mild upper airway infection
Feeling tired
Cough
When to contact a healthcare professional
A rash that does not go away
Wheezing or a persistent cough
Swollen glands in the neck, armpit, or groin
Bruising or bleeding more easily than usual
Swelling that spreads over your child's whole arm or leg where the shot was given
Blisters at the injection site
Any troublesome symptom that does not go away or seems to bother your child
When to get emergency help
Sudden swelling of the face, lips, mouth, tongue, or throat, or trouble breathing or swallowing
An itchy rash on the hands and feet with swelling around the eyes and face
A sudden drop in alertness, or your child becomes limp, unresponsive, or loses consciousness
A seizure (fit), with or without fever
Long pauses between breaths, especially in a baby born very prematurely
Other medicines and vaccines
Tell the healthcare professional about all medicines your child takes, including vitamins, minerals, or natural health products.
If your child is taking a blood thinner, tell the healthcare professional before this vaccine is given.
If your child is taking medicine that weakens the immune system, this vaccine may not work as well; talk to the healthcare professional about timing.
This is an injected vaccine, so food and feeding times do not affect how it works.
Key points to remember
Mild fever, fussiness, and soreness where the shot was given are common and usually go away within a few days.
Contact the healthcare professional if you are ever unsure whether your child is due for a dose.
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination. Public health recommendations may differ from a product monograph's authorized schedule.
DTaP-IPV-Hib-HepB (INFANRIX HEXA) — infant series
4 doses
Four doses at 2, 4, 6 and 18 months of age, including hepatitis B.
Six-in-one infant series used where hepatitis B is given in infancy. Doses at 2, 4, 6 and 12 to 23 months (generally 18 months). Infants born to mothers with hepatitis B need separate hepatitis B vaccine and immune globulin at birth.
Family guidance on pregnancy: Tdap is recommended in every pregnancy, irrespective of immunization history, ideally at 27 to 32 weeks. Polio (IPV) may be considered for a non-immune person at increased risk; Hib when a predisposing condition is present.
Family guidance on breastfeeding: Tdap is recommended if no adult dose has been given; polio and Hib are used if indicated.
General information only. A suggested date is not an appointment or a prescription; a healthcare professional confirms what you need. Clinical rules reviewed on 2026-09-27.